A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease.

Safarinejad MR, Asgari MA, Hosseini SY, Dadkhah F.

DOI: 10.1111/j.1464-410x.2009.09041.x
Published: 2009-10-26
Container: BJU Int
Publisher: Not recorded
Open access: no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/j.1464-410x.2009.09041.x,
  title = {A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease.},
  author = {Safarinejad MR and  Asgari MA and  Hosseini SY and  Dadkhah F.},
  year = {2010},
  journal = {BJU Int},
  doi = {10.1111/j.1464-410x.2009.09041.x},
  url = {https://doi.org/10.1111/j.1464-410x.2009.09041.x}
}

RIS

TY  - JOUR
TI  - A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease.
AU  - Safarinejad MR
AU  -  Asgari MA
AU  -  Hosseini SY
AU  -  Dadkhah F.
PY  - 2010
JO  - BJU Int
DO  - 10.1111/j.1464-410x.2009.09041.x
UR  - https://doi.org/10.1111/j.1464-410x.2009.09041.x
ER  -

APA

MR, S., MA, A., SY, H., & F., D. (2010). A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease.. BJU Int. https://doi.org/10.1111/j.1464-410x.2009.09041.x

Source records

europe-pmc · retrieved 2026-09-26T20:27:33.993Z